Diagnostic criteria of dementia

Canadian Journal of Neurological Sciences

Volumn 34, Issue SUPPL. 1, 2007, Pages

  Bouchard, Rémi W ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NOOTROPIC AGENT;

ALZHEIMER DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; CONFERENCE PAPER; DEMENTIA; DIAGNOSTIC PROCEDURE; DIFFUSE LEWY BODY DISEASE; DISEASE CLASSIFICATION; DISEASE COURSE; FRONTOTEMPORAL DEMENTIA; HUMAN; MEDICAL LITERATURE; MULTIINFARCT DEMENTIA; NEUROIMAGING; PRIORITY JOURNAL; STROKE;

EID: 34248596703     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0317167100005497     Document Type: Conference Paper

References (71)

1. Organizing Committee, Canadian consensus conference on the Assessment of Dementia: the Canadian consensus. Can Med Assoc J. 1991; 144:851-3.
2. American Psychiatric Association, Committee on Nomenclature and Statistics. Diagnostic and statistical manual of mental disorders, 3rd edn, revised. Washington, DC: American Psychiatric Association (1987).
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association (1994).
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. (IV-TR) . Washington, DC: American Psychiatric Association (2000).
5. Lopez OL, Becker JT, Klunk W, Saxton J, Hamilton RL, Kaufer DI. et al. Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: pt 1. Neurology. 2000;55: 1854-62.
6. Copeland MP, Daly E, Hines V, Mastromauro C, Zaitchik D, Gunther J, et al. Psychiatric Symptomatology and Prodromal Alzheimer's Disease. Alzheimer Dis Assoc Disord. 2003; 17:1-8.
7. Geerlings MI, Schmand B, Braam AW, Jonker C, Bouter LM, van Tilburg W. Depressive Symptoms and Risk of Alzheimer's Disease in more Highly Educated Older People. J Am Geriatr Soc. 2000;48:1092-7.
8. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment. JAMA. 2002;288:1475-83.
9. Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, et al. Practice parameter: Diagnosis of dementia (an evidence-based review); report of the Quality Standards Subcommittee of the American Academy of Neurology, Neurology. 2001; 56:1143-53.
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984; 34: 939-44.
11. Holmes C, Cairns N, Lantos P, Mann A. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry. 1999;174:45-50.
12. Blacker D, Albert MS, Basset SS, Go RC, Harrell LE, Folstein MF. Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. The National Institute of Mental Health Genetics Initiative. Arch Neurol. 1994; 51:1198-204.
13. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546-54.
14. Feldman H, Levy AR, Hsiung GY, Peters KR, Donald A, Black SE, et al. A Canadian cohort study of cognitive impairment and related dementia (ACCORD): Study methods and baseline-results. Neuroepidemiology. 2003; 22: 265-74.
15. Kertesz A, Munoz DG. Primary progressive aphasia and Pick complex. J Neurol Sci. 2003; 206: 97-107.
16. The Lund Manchester Groups. Clinical and neuropathological crirteria for Frontotemporal dementia. J Neurol Neurosurg Psychiatry. 1994 ; 57:416-8.
17. Miller BL, Ikonte C, Ponton M, Levy M, Boone K, Darby A, et al. A study of the Lund-Manchester research criteria for Frontotemporal dementia: clinical and single-photon emission CT correlations. Neurology. 1997; 46:937-42.
18. McKhann G M, Albert Marilyn S, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and Pathological Diagnosis of Frontotemporal Dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol. 2001;58:1803-9.
19. Kertesz A, Davidson W, McCabe P, Takagi K, Munoz D. Primary progressive aphasia: diagnosis, varieties, evolution. J Int Neuropsychol Soc. 2003; 9: 710-9.
20. Grosman M. Frontotemporal dementia: a review. J Int Neuropsychol Soc. 2002; 8: 566-83.
21. Gorno-Tempini ML, Dronkers NF, Rankin KP, Ogar JM, Phengrasamy L, Rosen HJ, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol. 2004; 55: 335-46.
22. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium. Neurology. 2005;65:1863-72.
23. Lopez OL, Litvan I, Catt KE, Stowe R, Klunk W, Kaufer DI, et al. Accuracy of four diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology. 1999;53:1292-9.
24. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996; 47: 1113-24.
25. McKeith IG, Perry EK, Perry RH. Report of the second dementia with Lewy body international workshop. Neurology. 1999;53:902-5.
26. Korszvn AD. Dementia in Parkinson's disease. J Neurol. 2001; 248 (Suppl 3): III/1-III/4.
27. Mayeux R, Denaro J, Hemenegildo N, Marder K, Tang MX, Cote LJ, et al. A population-based investigation of Parkinson's disease with and without dementia: relationship to age and gender. Arch Neurol. 1992;49:492-7.
28. Aarsland D, Tandberg E, Larson JP, Cummings JL. Frequency of dementia in Parkinson's disease. Arch Neurol. 1996;53:538-42.
29. Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sorensen P. Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurology. 2001;56:730-6.
30. Emre, M. Dementia associated with Parkinson's disease. THE Lancet Neurol. 2003; 2:229-37.
31. Boller F, Mizutani T, Roessmann U, Gambetti P. Parkinson Disease, Dementia, and Alzheimer's Disease: Clinicopathological Correlations. Ann Neurol. 1980;7:329-35.
32. Braak H, Rüb U, Jansen Steur ENH, Del Tredici K, de Vos RA. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology. 2005;64:1404-10.
33. Leverenz JB, Fishel MA, Peskind ER, Montine TJ, Nochlin D, Steinbart E, et al. Lewy Body Pathology in Familial Alzheimer Disease. Arch Neurol. 2006;63:370-6.
34. Erisi MM, Wilcock GK, Morris JH. Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry. 1997;63:749-53.
35. Tomlinson BE, Blessed G, Roth M. Observations on the brain of demented old people. J Neurol Sci. 1970;11:205-42.
36. Hansen, LA, Samuel, W. Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies. Neurology. 1997;48:126-32.
37. Hughes AJ, Daniel SE, Blankson, S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol. 1993;50:140-8.
38. McKeith I, Mintzer J, Aarsland D, Burn D, Chui H, Cohen-Mansfield J, et al. Dementia with Lewy bodies. Lancet Neurology. 2004;3:19-28.
39. Rogers RD, Sahakian BJ, Hodges JR, Polkey CE, Kennard C, Robbins TW. Dissociating executive mechanisms of task control following frontal lobe and Parkinson's disease. Brain. 1998;121:815-42.
40. Litvan I, Mohr E, Williams J, Gomez C, Chase TN. Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1991;54:25-9.
41. Pillon B, Boller F, Levy R, Dubois B. Cognitive deficits and dementia in Parkinson's disease. In: Boller F, Cappa S, eds. Handbook of Neuropsychology. 2edn. Amsterdam: Elsevier Science. 2001:311-71.
42. Knopman DS, Rocca WA, Cha RH, Eldman SD, Kokmen E. Incidence of vascular dementia in Rochester, Minn, 1985-1989. Arch Neurol. 2002;59:1605-10.
43. Lopez OL, Kuller LH, Becker JT, Jagust WJ, DeKosky ST, Fitzpatrick A, et al. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study. Neurology. 2005; 64:1539-47.
44. Bowler JV. Vascular Cognitive impairment. J Neurol Neurosurg Psychiatry. 2005;76(Suppl V):v35-v44.
45. O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, et al. Vascular cognitive impairment. Lancet Neurology. 2003; 2:89-98.
46. Roman G, Sachdev P, Royall DR, Bullock RA, Oogogozo JM, Lopez-Pousa S, et al. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia . J Neurol Sci. 2004;226:81-7.
47. Sachdev P. Vascular cognitive disorder. Int J Geriatr Psychiatry. 1999;14:402-3.
48. Erkinjuntti T, Roman G, Chui H. Diagnostic criteria. In : Erkinjuntti T, Gauthier S, eds. Vascular cognitive impairment. London: Martin Dunitz 2002:43-58.
49. Rockwood K, Black SE, Song X, Hogan DB, Gauthier S, Macknight C, et al. Clinical and radiographic subtypes of vascular cognitive impairment in a clinic-based cohort study. J Neurol Sci. 2006; 240 (1-2):7-14.
50. Rockwood K, Bowler J, Erkinjuntti T, Hachinski V, Wallin A. Subtypes of vascular dementia. Alzheimer Dis Assoc Disord. 1999; 13 Suppl 3 :S59-65.
51. World Health Organisation. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and diagnostic Guidelines. Geneva: World Health Organisation. 1992:50-1.
52. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology. 1992;42:473-80.
53. Roman G, Tatemichi TK, Erkinjuntti T, the NINDS-AIREN Workgroup. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International workshop. Neurology. 1993; 43: 250-60.
54. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol. 1980; 7:486-8.
55. Pantoni L, Garcia JH, Brown GG. Vascular pathology in three cases of progressive cognitive deterioration. J Neurol Sci. 1996;135:131-9.
56. Hulette, C, Nochlin, D, McKeel DW, Morris JC, Mirra SS, Sumi SM, et al. Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases. Neurology. 1997;48:668-72.
57. Wettering T, Kanitz RD, Borgis KJ. Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV. ICD-10, NINDS-AIREN). Stroke. 1996;27:30-6.
58. Crook T, Bartus, RT, Ferris SH, Whitehouse P, Cohen GD, Gershon S. Age-associate memory impairment: proposed diagnostic criteria and measures of clinical changes: report of the National Institute of Mental Health Work Group. Dev Neuropsychol. 1986; 2:261-76.
59. Ebly EM, Hogan DB, Parhad I. Cognitive impairment in the non demented elderly. Results from the Canadian Study of Health and Aging (CSHA), Arch Neurol. 1995; 52:612-9.
60. Levy R. Aging-Associated cognitive Decline. Int Psychogeriatr. 1994; 6:63-68
61. Feldman HH, Jacova, C. Mild Cognitive impairment. Am J Geriatr Psychiatry. 2005; 13:645-55.
62. Saxton J, Lopez OL, Ratcliff G, Dulberg C, Fried LP, Carlson MC. Preclinical Alzheimer disease: Neuropsychological test performance 1.5 to 8 years prior to onset. Neurology. 2004;63:2341-47.
63. Morris JC, Storandt M, Miller JP, Mckeel DW, Price JL, Rubin EH. Mild cognitive impairment represents early-stage Alzheimer's disease. Arch Neurol. 2001;58:397-405.
64. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56 :303-8.
65. Schröder J, Kratz B, Pantel J, Minnemann E, Lehr U, Sauer H. Prevalence of mild cognitive impairment in an elderly community sample. J Neural Transm. 1998 (Suppl.): 54: 51-9.
66. Loewenstein DA, Acevedo A, Argon J, Issacson R, Strauman S, Crocco E, et al. Cognitive profiles in Alzheimer's disease and in mild cognitive impairment of different etiologies. Dement Geriatr Cogn Disord. 2006;21(5-6):309-15.
67. Ribeiro F, de Mendonca A, Guerreiro M. Mild cognitive impairment: deficits in cognitive domains other than memory. Dement Geriatr Cogn Disord. 2006;21(5-6):284-90.
68. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001; 58:1985-92.
69. Grundman M., Petersen RC, Morris JC, Ferris S, Sano M, Farlow MR, et al. Rate of dementia of Alzheimer type (DAT) in subjects with mild cognitive impairment: the Alzheimer's Disease Cooperative Study (Abstract). Neurology. 1996; 46:A403.
70. Petersen RC, Parisi JE, Dickson DW, Johnson KA, Knopman DS, Boeve BF, et al. Neuropathological features of amnestic mild cognitive impairment. Arch Neurol.2006; 63:665-72.
71. Jicha GA, Parisi JE, Dickson DW, Johnson K, Cha R, Ivnik RJ, et al. Neuropathological outcome of mild cognitive impairment following progression to clinical Dementia. Arch Neurol. 2006;63:674-81.